Methadone and buprenorphine treatment in United States jails and prisons: lessons from early adopters.

Sachini Bandara Alene Kennedy-Hendricks Sydney Merritt Colleen L Barry Brendan Saloner

Published in: Addiction (Abingdon, England) (2021)

Despite identifying regulatory and logistical challenges, early adopters of opioid agonist treatment (OAT) programs in US jails and prisons demonstrate that OAT programs can successfully be implemented in carceral settings with tailoring to the specific context.

Keyphrases

chronic pain
transcription factor
replacement therapy